Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker

Neoplasia

Volumn 10, Issue 6, 2008, Pages 521-533

  Golan, Maya ^a   Hizi, Amnon ^a   Resau, James H ^b   Yaal Hahoshen, Neora ^a   Reichman, Hadar ^a   Keydar, Iafa ^a   Tsarfaty, Ilan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; ESTROGEN; HERV K T47D REVERSE TRANSCRIPTASE PROTEIN; PARAFFIN; POLYCLONAL ANTIBODY; PROGESTERONE; RNA DIRECTED DNA POLYMERASE; SMALL INTERFERING RNA;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BREAST BIOPSY; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER SURVIVAL; CELL STRAIN MCF 7; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS K; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROVIRUS; SEQUENCE ANALYSIS; TUMOR BIOPSY;

EID: 44349195776     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07986     Document Type: Article

References (66)

1. Herbst RS, Bajorin DF, Bleiberg H, Blum D, Hao D, Johnson BE, Ozols RF, Demetri GD, Ganz PA, Kris MG, et al. (2006). Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology. J Clin Oncol 24, 190-205.
2. McPherson K, Steel CM, and Dixon JM (2000). ABC of breast diseases. Breast cancer - epidemiology, risk factors and genetics. BMJ 321, 624-628.
3. Kelsey JL and Bernstein L (1996). Epidemiology and prevention of breast cancer. Annu Rev Public Health 17, 47-67.
4. Hulka BS and Moorman PG (2001). Breast cancer: hormones and other risk factors. Maturitas 38, 103-113; discussion 113-106.
5. Bittner J (1936). Some possible effect of nursing on the mammary tumor incidence. Science 84, 62.
6. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
7. Larsson E, Kato N, and Cohen M (1989). Human endogenous proviruses. Curr Top Microbiol Immunol 148, 115-132.
8. Leib-Mosch C, Brack-Werner R, Werner T, Bachmann M, Faff O, Erfle V, and Hehlmann R (1990). Endogenous retroviral elements in human DNA. Cancer Res 50, 5636S-5642S.
9. Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, and Meese E (1999). An almost-intact human endogenous retrovirus K on human chromosome 7. Nat Genet 21, 257-258.
10. Tonjes RR, Czauderna F, and Kurth R (1999). Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol 73, 9187-9195.
11. Lower R, Lower J, and Kurth R (1996). The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 93, 5177-5184.
12. Keydar I, Ohno T, Nayak R, Sweet R, Simoni F, Weiss F, Karby S, Mesa-Tejada R, and Spiegelman S (1984). Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proc Natl Acad Sci USA 81, 4188-4192.
13. Ono M, Kawakami M, and Ushikubo H (1987). Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol 61, 2059-2062.
14. Keydar I, Selzer G, Chaitchik S, Hareuveni M, Karby S, and Hizi A (1982). A viral antigen as a marker for the prognosis of human breast cancer. Eur J Cancer Clin Oncol 18, 1321-1328.
15. Segev N, Hizi A, Kirenberg F, and Keydar I (1985). Characterization of a protein, released by the T47D cell line, immunologically related to the major envelope protein of mouse mammary tumor virus. Proc Natl Acad Sci USA 82, 1531-1535.
16. Medstrand P and Blomberg J (1993). Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J Virol 67, 6778-6787.
17. Seifarth W, Skladny H, Krieg-Schneider F, Reichert A, Hehlmann R, and Leib-Mosch C (1995). Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J Virol 69, 6408-6416.
18. Patience C, Simpson GR, Colletta AA, Welch HM, Weiss RA, and Boyd MT (1996). Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line. J Virol 70, 2654-2657.
19. Seifarth W, Baust C, Murr A, Skladny H, Krieg-Schneider F, Blusch J, Werner T, Hehlmann R, and Leib-Mosch C (1998). Proviral structure, chromosomal location, and expression of HERV-K-T47D, a novel human endogenous retrovirus derived from T47D particles. J Virol 72, 8384-8391.
20. Berkhout B, Jebbink M, and Zsiros J (1999). Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J Virol 73, 2365-2375.
21. Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, and Strong TV (2001). Expression of human endogenous retrovirus K envelope transcripts in human breast cancer. Clin Cancer Res 7, 1553-1560.
22. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, and Johanning GL (2003). Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22, 1528-1535.
23. Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, and Pogo BG (2001). Identification of a proviral structure in human breast cancer. Cancer Res 61, 1754-1759.
24. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, and Brenner HJ (1979). Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15, 659-670.
25. Owens RB and Hackett AJ (1972). Tissue culture studies of mouse mammary tumor cells and associated viruses. J Natl Cancer Inst 49, 1321-1332.
26. Berdichevsky F, Alford D, D'Souza B, and Taylor-Papadimitriou J (1994). Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci 107 (Pt 12), 3557-3568.
27. Tonjes RR, Boller K, Limbach C, Lugert R, and Kurth R (1997). Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses. Virology 233, 280-291.
28. Taube R, Loya S, Avidan O, Perach M, and Hizi A (1998). Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization. Biochem J 329, 579-587.
29. Harlow E and Lane D (1988). Antibodies - A Laboratory Manual. New York, NY: Cold Spring Harbor Laboratory.
30. Sambrook A, Fritsch EF, and Maniatis T (1989). Molecular Cloning. A Laboratory Manual. New York, NY: Cold Spring Harbor Laboratory.
31. Brummelkamp TR, Bernards R, and Agami R (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
32. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
33. Chen C and Okayama H (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7, 2745-2752.
34. Tsarfaty I, Alvord WG, Resau JH, Altstock RT, Lidereau R, Bieche I, Bertrand F, Horev J, Klabansky RL, Keydar I, et al. (1999). Alteration of met proto-oncogene product expression and prognosis in breast carcinomas. Anal Quant Cytol Histol 21, 397-408.
35. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, and Vande Woude GF (1992). The met proto-oncogene receptor and lumen formation. Science 257, 1258-1261.
36. Shaharabany M, Rice NR, and Hizi A (1993). Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus. Biochem Biophys Res Commun 196, 914-920.
37. Kaplan EL and Meier P (1958). Nonparametric estimation from incomplete observations. J Am Stat Soc 53, 457-481.
38. Altstock RT, Stein GY, Resau JH, and Tsarfaty I (2000). Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in cancer: met oncogene expression, and breast cancer as a model. Cytometry 41, 155-165.
39. Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, and Kurth R (1993). Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA 90, 4480-4484.
40. Xiong Y and Eickbush TH (1988). Similarity of reverse transcriptase-like sequences of viruses, transposable elements, and mitochondrial introns. Mol Biol Evol 5, 675-690.
41. Awad R, Medstrand P, Yin H, Andersson M-L, and Blomberg J (2003). Open reading frames and associated enzymatic activities in the polymerase gene of human endogenous retroviral HERV-K(HML-2) sequences. Department of Medical Sciences. Uppsala, Sweden: Uppsala University.
42. Sharma PL, Nurpeisov V, and Schinazi RF (2005). Retrovirus reverse transcriptases containing a modified YXDD motif. Antivir Chem Chemother 16, 169-182.
43. Harris D, Yadav PN, and Pandey VN (1998). Loss of polymerase activity due to Tyr to Phe substitution in the YMDD motif of human immunodeficiency virus type-1 reverse transcriptase is compensated by Met to Val substitution within the same motif. Biochemistry 37, 9630-9640.
44. Kaushik N, Singh K, Alluru I, and Modak MJ (1999). Tyrosine 222, a member of the YXDD motif of MuLV RT, is catalytically essential and is a major component of the fidelity center. Biochemistry 38, 2617-2627.
45. Brooks SC, Locke ER, and Soule HD (1973). Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248, 6251-6253.
46. Cassanelli S, Louis J, and Seigneurin D (1995). Progesterone receptor heterogeneity in MCF-7 cell subclones is related to clonal origin and kinetics data. Tumour Biol 16, 222-229.
47. Ono M (1986). Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J Virol 58, 937-944.
48. Faff O, Murray AB, Schmidt J, Leib-Mosch C, Erfle V, and Hehlmann R (1992). Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumour virus and are of human endogenous origin. J Gen Virol 73 (Pt 5), 1087-1097.
49. Avidan O, Loya S, Tonjes RR, Sevilya Z, and Hizi A (2003). Expression and characterization of a recombinant novel reverse transcriptase of a porcine endogenous retrovirus. Virology 307, 341-357.
50. Avidan O, Bochner R, and Hizi A (2006). The catalytic properties of the recombinant reverse transcriptase of bovine immunodeficiency virus. Virology 351, 42-57.
51. Perach M and Hizi A (1999). Catalytic features of the recombinant reverse transcriptase of bovine leukemia virus expressed in bacteria. Virology 259, 176-189.
52. Lower J, Wondrak EM, and Kurth R (1987). Genome analysis and reverse transcriptase activity of human teratocarcinoma-derived retroviruses. J Gen Virol 68 (Pt 11), 2807-2815.
53. Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, and Tristem M (2005). Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol 79, 12507-12514.
54. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, and Tristem M (2004). Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci USA 101, 4894-4899.
55. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, and Lenz J (2001). Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 11, 1531-1535.
56. Macfarlane C and Simmonds P (2004). Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J Mol Evol 59, 642-656.
57. Zhu ZB, Hsieh SL, Bentley DR, Campbell RD, and Volanakis JE (1992). A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J Exp Med 175, 1783-1787.
58. Dangel AW, Mendoza AR, Baker BJ, Daniel CM, Carroll MC, Wu LC, and Yu CY (1994). The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 40, 425-436.
59. Jones KA, Black DM, Brown MA, Griffiths BL, Nicolai HM, Chambers JA, Bonjardim M, Xu CF, Boyd M, McFarlane R, et al. (1994). The detailed characterisation of a 400 kb cosmid walk in the BRCA1 region: identification and localisation of 10 genes including a dual-specificity phosphatase. Hum Mol Genet 3, 1927-1934.
60. Sedlacek Z, Korn B, Konecki DS, Siebenhaar R, Coy JF, Kioschis P, and Poustka A (1993). Construction of a transcription map of a 300 kb region around the human G6PD locus by direct cDNA selection. Hum Mol Genet 2, 1865-1869.
61. Levine KL, Steiner B, Johnson K, Aronoff R, Quinton TJ, and Linial ML (1990). Unusual features of integrated cDNAs generated by infection with genome-free retroviruses. Mol Cell Biol 10, 1891-1900.
62. Maestre J, Tchenio T, Dhellin O, and Heidmann T (1995). mRNA retroposition in human cells: processed pseudogene formation. EMBO J 14, 6333-6338.
63. Tchenio T, Segal-Bendirdjian E, and Heidmann T (1993). Generation of processed pseudogenes in murine cells. EMBO J 12, 1487-1497.
64. Sinibaldi-Vallebona P, Lavia P, Garaci E, and Spadafora C (2006). A role for endogenous reverse transcriptase in tumorigenesis and as a target in differentiating cancer therapy. Genes Chromosomes Cancer 45, 1-10.
65. Rabkin CS (2001). AIDS and cancer in the era of highly active antiretroviral therapy (HAART). Eur J Cancer 37, 1316-1319.
66. Laurence J (2003). Drug resistance among HIV and its "friends". AIDS Read 13, 103; 107.